ClearPoint Neuro, Inc. (CLPT) vs Enanta Pharmaceuticals, Inc. (ENTA)
A side-by-side comparison of ClearPoint Neuro, Inc. and Enanta Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLPT
ClearPoint Neuro, Inc.
$11.52HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
ENTA
Enanta Pharmaceuticals, Inc.
$12.60HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — CLPT vs ENTA
growth of $100 · dividends reinvested · last 10yCLPT +88.9% (+6.6%/yr)ENTA -52.4% (-7.2%/yr)CLPT compounded faster over this window
CLPT ENTA
CLPT vs ENTA: by the numbers
- •ENTA is the larger company ($366M vs $345M market cap).
- •Both run net losses; CLPT's is the smaller (-81.76% vs -96.89% net margin).
- •CLPT grew revenue faster over the past five years (23.57% vs -7.65% CAGR).
Metrics side by side
Valuation
| Metric | CLPT | ENTA |
|---|---|---|
| P/S ratio | 8.17 | 5.61 |
| P/B ratio | 32.06 | 3.63 |
Profitability
| Metric | CLPT | ENTA |
|---|---|---|
| Gross margin | 62.61% | 98.15% |
| Operating margin | -65.36% | -130.65% |
| Net margin | -81.76% | -96.89% |
| ROE | -320.77% | -62.56% |
| ROIC | -40.51% | -24.20% |
Growth (annualized)
| Metric | CLPT | ENTA |
|---|---|---|
| Revenue CAGR (5Y) | 23.57% | -7.65% |
| Total return CAGR (5Y) | -7.65% | -26.94% |
Frequently asked
- Which has grown faster, CLPT or ENTA?
- Over the past five years, CLPT grew revenue faster — CLPT at a 23.57% CAGR versus ENTA at -7.65%.
- How have CLPT and ENTA total returns compared?
- Over the past 10 years, CLPT delivered 6.57% and ENTA delivered -7.11% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ClearPoint Neuro ROEEnanta Pharmaceuticals ROEClearPoint Neuro operating marginEnanta Pharmaceuticals operating marginClearPoint Neuro revenue growthEnanta Pharmaceuticals revenue growthClearPoint Neuro free cash flowEnanta Pharmaceuticals free cash flow
ClearPoint Neuro & Enanta Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.